Virax Biolabs COO Secures 20,000 New Options Amid Share‑Price Rally—Signals Long‑Term Confidence in Turnaround Strategy
Virax Biolabs insider option grant signals CEO confidence in turnaround; reveals governance upgrades, potential upside for investors despite low share price.
2 minutes to read